Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI lifestyle coach may shield aging brains

NCT ID NCT07766993

Prevention Sponsor: National Research Center for Rehabilitation Technical Aids Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 17, 2026 · Last updated Aug 19, 2026 · Updated 2 times

Summary

This study tests whether an AI-assisted lifestyle program can help adults aged 40 and older without cognitive impairment maintain their memory and thinking skills. Participants receive personalized advice on diet, exercise, mental activities, and social engagement through an online platform. The trial compares those with healthier lifestyles to those with less healthy ones, measuring cognitive function, lifestyle habits, and blood markers related to Alzheimer's disease over one year.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AI-assisted lifestyle intervention program
What this could lead to
If successful, this could point toward a practical, personalized way to help people maintain memory and thinking as they age, potentially reducing the risk of cognitive decline.
What could go wrong
This is an early-stage trial with 100 participants, so results may not apply broadly. The program relies on self-reported lifestyle changes, and the link to blood markers is exploratory.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Chinese community-dwelling residents aged ≥ 40 years; 2. Cognitive function adequate to cooperate with testing and interventions; 3. No history of major neurological or psychiatric disorders; 4. Not on long-term use of medications known to affect cognitive function significantly ; 5. Possess the basic access and ability to use smartphones or the internet to receive online interventions; 6. Good compliance, with the expected ability to adhere to and complete a 1-year follow-up. Exclusion Criteria: 1. Age \< 40 years; 2. Cognitive function inadequate to cooperate with testing and interventions; 3. History of major neurological disorders (e.g., stroke, Parkinson's disease, brain tumors, epilepsy) or severe psychiatric disorders (e.g., schizophrenia, severe depressive episodes); 4. Currently taking medications known to significantly affect cognitive function (e.g., anticholinergic drugs, certain psychotropic medications); 5. Presence of severe systemic or physical illnesses (e.g., advanced malignancy, severe heart, lung, liver, or kidney failure); 6. Lack of access to smartphones or the internet, rendering the participant unable to receive online interventions; 7. Any other conditions deemed by the investigator as inappropriate for participation in this study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive function above the mci threshold are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cognitive function above the mci threshold Intact cognitive function MCI Mild dementia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.